The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug midomafetamine, also known as MDMA or the street drug ecstasy ...

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

Sally Roberts, a world-class wrestler and Army veteran, credits psychedelic-assisted therapy with saving her life from PTSD.

Minutes joined U.S. veterans with PTSD on a week-long psychedelic retreat in Mexico. Nearly a year later, most of the vets ...

The state's new law marks one of the largest government investments into psychedelics to date, with advocates citing the drug ...

However, Ben Hargreaves finds the FDA rejection of Lykos’ MDMA-based drug for PTSD raises fresh concerns about the future of these treatments and their path to regulatory approval. Despite this ...

The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD ... MDMA is not approved for clinical use by the U.S. Food and Drug Administration ...

In today’s news, Anthony Albanese could meet Donald Trump next week at NATO, the High Court rejects a CFMEU challenge to administration laws, and markets’ biggest Iran fears edge closer.

Three weeks after the attack, scientists at Reichman University began this one-of-a-kind study asking, How did drug ... research, MDMA use was not associated with reduced anxiety or PTSD symptoms ...

The Supreme Court is siding with e-cigarette companies in a ruling that'll make it easier to sue over Food and Drug ...

Abbott signed Senate Bill 2308 on Wednesday, stating it will position Texas at the forefront of making ibogaine accessible to ...